VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses - Archive ouverte HAL Access content directly
Journal Articles Brain, Behavior, and Immunity Year : 2014

VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses

Domains

Life Sciences [q-bio] Life Sciences [q-bio] Immunology Life Sciences [q-bio] Immunology Adaptive immunology Life Sciences [q-bio] Neurons and Cognition [q-bio.NC]
Fichier principal
Vignette du fichier
Tan et al BBI 2015.pdf (1.1 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Yossan-Var TAN  : Connect in order to contact the contributor

https://hal-normandie-univ.archives-ouvertes.fr/hal-02377405

Submitted on : Saturday, November 23, 2019-5:14:28 PM

Last modification on : Thursday, April 28, 2022-3:20:02 PM

Long-term archiving on: Monday, February 24, 2020-2:00:59 PM

Download

Dates and versions

hal-02377405 , version 1 (23-11-2019)

Identifiers

  • HAL Id : hal-02377405 , version 1

Cite

Yossan-Var Tan, Catalina Abad, Yuqi Wang, Robert Lopez, James A Waschek. VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses. Brain, Behavior, and Immunity, 2014. ⟨hal-02377405⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM COMUE-NORMANDIE UNIROUEN U1234PANTHER
63 View
80 Download

Share

Gmail Facebook Twitter LinkedIn More